Beyond the Signal: KuCoin Marks Its 9th Anniversary With a Multi-Track Competition and Total Rewards of Up to 650,000 USDT
Spanning Spot, Futures, VIP, Earn, Payment, Mining and Web3 Wallet, the campaign connects user rewards with broader participation across the KuCoin ecosystem PROVIDENCIALES,... Read more.
City of Munich selects CGI to advance digital government services and technological sovereignty
Stock Market SymbolsGIB.A (TSX)GIB (NYSE)cgi.com/newsroom CGI will help streamline administrative processes, expand digital services for citizens and support resilient... Read more.
Ascletis Announces Once-Monthly Subcutaneously Administered GLP-1R/GIPR/GCGR Triple Peptide Agonist, ASC37, Demonstrated Superior Weight Loss in a Diet-Induced Obese Mouse Model
-ASC37 demonstrated statistically significant 88% greater relative body weight reduction compared to tirzepatide in the diet-induced obese (DIO) mouse model.-Both... Read more.
Best Progressive Reading Glasses (2026): EZContacts Awarded Top Choice for Online Eyewear Shopping by Better Business Advice
NEW YORK, July 27, 2026 /PRNewswire/ — Better Business Advice named EZContacts a top online eyewear retailer for 2026, pointing to its reading glasses catalog,... Read more.
BlackWolf Advisory Group and Authority Partners Team Up to Bring Custom AI Solutions to Mortgage Firms
Partnership gives lenders and servicers a direct path to build AI platforms from the ground up or to expand existing technology without hiring an internal development... Read more.
KMM Group Receives Investment from RS2 Healthcare Partners
J. Mark King Joins as Chief Executive Officer to Support Next Phase of Growth HATBORO, Pa., July 27, 2026 /PRNewswire/ — KMM Group (“KMM” or the... Read more.
SourceAmerica Presents Improvements in Disability Employment to National Council on Disability
VIENNA, Va., July 27, 2026 /PRNewswire/ — New data from SourceAmerica® emphasizes the AbilityOne® Program’s measurable, positive impact on the lives... Read more.
IDEAYA Biosciences Announces IDE892, a Potential Best-in-Class MTA-Cooperative PRMT5 Inhibitor, Initiates Part 2 Monotherapy Expansion in the Phase 1/2 Study in MTAP-Deleted Pancreatic and Lung Cancers
IDE892 is a potential best-in-class PRMT5 inhibitor with 1,400-fold selective MTA-PRMT5 cooperative binding vs SAM-PRMT5 cooperative binding, and CYP3A4 IC50 greater... Read more.
Bambusa Therapeutics Reports Potentially Transformative Preliminary Proof-of-Concept Results for BBT001 in Atopic Dermatitis, Reinforcing Its Best-in-Disease Potential
BBT001 delivered highly statistically significant and clinically meaningful improvement in EASI beginning at Week 1, with responses continuing to improve over time... Read more.
HashKey Exchange Launches New Flagship Crypto Trading App
HONG KONG, July 27, 2026 /PRNewswire/ — HashKey Holdings Limited (3887.HK), a comprehensive Asian digital asset group, announced a landmark global product... Read more.